Tianhai Ji

1.3k total citations
38 papers, 1.1k citations indexed

About

Tianhai Ji is a scholar working on Molecular Biology, Cancer Research and Biomedical Engineering. According to data from OpenAlex, Tianhai Ji has authored 38 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 10 papers in Cancer Research and 8 papers in Biomedical Engineering. Recurrent topics in Tianhai Ji's work include Advanced biosensing and bioanalysis techniques (8 papers), Biosensors and Analytical Detection (7 papers) and Glioma Diagnosis and Treatment (4 papers). Tianhai Ji is often cited by papers focused on Advanced biosensing and bioanalysis techniques (8 papers), Biosensors and Analytical Detection (7 papers) and Glioma Diagnosis and Treatment (4 papers). Tianhai Ji collaborates with scholars based in China and United States. Tianhai Ji's co-authors include Chaoyong Yang, Zhi Zhu, Dan Liu, Jiuxing Li, Wei Shao, Zhichao Guan, Shasha Jia, Bingqian Lin, Wensheng Yang and Zhi‐Chao Lei and has published in prestigious journals such as Angewandte Chemie International Edition, Nature Communications and ACS Nano.

In The Last Decade

Tianhai Ji

37 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tianhai Ji China 17 774 536 152 131 87 38 1.1k
Yuna Guo China 23 889 1.1× 431 0.8× 183 1.2× 130 1.0× 66 0.8× 46 1.4k
Yihong Wang China 20 766 1.0× 314 0.6× 322 2.1× 152 1.2× 36 0.4× 91 1.5k
Lin Shi China 21 964 1.2× 422 0.8× 271 1.8× 232 1.8× 38 0.4× 61 1.6k
Yuxuan Li China 16 800 1.0× 288 0.5× 172 1.1× 189 1.4× 33 0.4× 53 1.1k
Lijia Zhang China 15 867 1.1× 363 0.7× 289 1.9× 110 0.8× 23 0.3× 56 1.4k
Li Zou China 24 1.1k 1.5× 438 0.8× 328 2.2× 342 2.6× 41 0.5× 82 1.8k
Minhao Xie China 23 1.1k 1.4× 526 1.0× 337 2.2× 103 0.8× 186 2.1× 58 1.4k
Mengying Wang China 17 530 0.7× 203 0.4× 138 0.9× 55 0.4× 20 0.2× 51 863

Countries citing papers authored by Tianhai Ji

Since Specialization
Citations

This map shows the geographic impact of Tianhai Ji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tianhai Ji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tianhai Ji more than expected).

Fields of papers citing papers by Tianhai Ji

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tianhai Ji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tianhai Ji. The network helps show where Tianhai Ji may publish in the future.

Co-authorship network of co-authors of Tianhai Ji

This figure shows the co-authorship network connecting the top 25 collaborators of Tianhai Ji. A scholar is included among the top collaborators of Tianhai Ji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tianhai Ji. Tianhai Ji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bai, Xue‐Feng, et al.. (2025). GCN5-targeted dual-modal probe across the blood-brain barrier for borders display in invasive glioblastoma. Nature Communications. 16(1). 2345–2345. 5 indexed citations
2.
Xie, Qihui, Jianzhou Feng, Qian Fan, et al.. (2024). Tumor Exosomal ENPP1 Hydrolyzes cGAMP to Inhibit cGAS‐STING Signaling. Advanced Science. 11(20). e2308131–e2308131. 31 indexed citations
3.
Wang, Wenjun, et al.. (2024). Metabolic remodeling by the PD-L1 inhibitor BMS-202 significantly inhibits cell malignancy in human glioblastoma. Cell Death and Disease. 15(3). 186–186. 7 indexed citations
4.
Gao, Duo, et al.. (2023). Oral Delivery of Gemcitabine-Loaded Glycocholic Acid-Modified Micelles for Cancer Therapy. ACS Nano. 17(18). 18074–18088. 14 indexed citations
5.
Yu, Guopeng, Bo Liang, Ming Zhan, et al.. (2022). Identification of Metabolism-Related Gene-Based Subgroup in Prostate Cancer. Frontiers in Oncology. 12. 909066–909066. 2 indexed citations
6.
Zhu, Jinchao, et al.. (2022). Cell origin and genome profile difference of penoscrotum invasive extramammary Paget disease compared with its in situ counterpart. Frontiers in Oncology. 12. 972047–972047. 2 indexed citations
7.
Lin, Qingyuan, et al.. (2022). The pro-invasive factor COL6A2 serves as a novel prognostic marker of glioma. Frontiers in Oncology. 12. 897042–897042. 9 indexed citations
8.
Lin, Qingyuan, et al.. (2021). DNase I-assisted 2′-O-methyl molecular beacon for amplified detection of tumor exosomal microRNA-21. Talanta. 235. 122727–122727. 6 indexed citations
9.
Chen, Jing, et al.. (2020). Rivaroxaban ameliorates angiotensin II-induced cardiac remodeling by attenuating TXNIP/Trx2 interaction in KKAy mice. Thrombosis Research. 193. 45–52. 11 indexed citations
10.
Tao, Qian, Xinyi Wu, Qingyuan Lin, et al.. (2018). Portable detection of serum HER-2 in breast cancer by a pressure-based platform. Analytical and Bioanalytical Chemistry. 410(28). 7489–7498. 8 indexed citations
11.
Lin, Bingqian, Dan Liu, Jinmao Yan, et al.. (2016). Enzyme-Encapsulated Liposome-Linked Immunosorbent Assay Enabling Sensitive Personal Glucose Meter Readout for Portable Detection of Disease Biomarkers. ACS Applied Materials & Interfaces. 8(11). 6890–6897. 68 indexed citations
12.
Gu, Jinping, Xiaomin Hu, Wei Shao, et al.. (2016). Metabolomic analysis reveals altered metabolic pathways in a rat model of gastric carcinogenesis. Oncotarget. 7(37). 60053–60073. 39 indexed citations
13.
Liu, Kun, Haitao Lan, Liping Wang, et al.. (2015). GCN5 Potentiates Glioma Proliferation and Invasion via STAT3 and AKT Signaling Pathways. International Journal of Molecular Sciences. 16(9). 21897–21910. 36 indexed citations
14.
Li, Xilan, Yuan An, Jiang Jin, et al.. (2015). Evolution of DNA Aptamers through in Vitro Metastatic-Cell-Based Systematic Evolution of Ligands by Exponential Enrichment for Metastatic Cancer Recognition and Imaging. Analytical Chemistry. 87(9). 4941–4948. 53 indexed citations
15.
Zhu, Zhi, Zhichao Guan, Dan Liu, et al.. (2015). Translating Molecular Recognition into a Pressure Signal to enable Rapid, Sensitive, and Portable Biomedical Analysis. Angewandte Chemie International Edition. 54(36). 10448–10453. 163 indexed citations
16.
Shao, Wei, Jinping Gu, Caihua Huang, et al.. (2014). Malignancy-associated metabolic profiling of human glioma cell lines using 1H NMR spectroscopy. Molecular Cancer. 13(1). 197–197. 55 indexed citations
17.
Zhang, Haiping, et al.. (2010). [Screening for K-ras mutations in colorectal and lung cancers by using a novel real-time PCR with ADx-K-ras kit and Sanger DNA sequencing].. PubMed. 39(11). 757–61. 1 indexed citations
18.
Ji, Tianhai, et al.. (2009). Expression of homeobox B7 in breast cancers and its clinical significance.. Zhongguo redai yixue. 9(9). 1697–1806. 1 indexed citations
19.
Ji, Tianhai. (2008). Disseminated Histoplasmosis:A Case Report and Review Literature. 1 indexed citations
20.
Ji, Tianhai, et al.. (2006). Study of Cajal interstitial cells in intestine of rats with liver cirrhosis. Academic Journal of Second Military Medical University. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026